Navigation Links
PURE Bioscience Schedules Second Quarter 2009 Financial Results Conference Call for March 12, 2009 at 1:30 P.M. PDT
Date:3/10/2009

SAN DIEGO, March 10 /PRNewswire-FirstCall/ -- PURE Bioscience (Nasdaq: PURE) today announced that Michael L. Krall, President and CEO, will host a conference call on Thursday, March 12th at 1:30 P.M. PDT to review and discuss second quarter 2009 financial results.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO)

Shareholders and other interested parties may participate in the conference call by dialing 877-407-8033 or (International) 201-689-8033 a few minutes before 1:30 P.M. PDT on March 12th, 2009.

The call is being webcast by Vcall and can be accessed at www.purebio.com. Investors can also access the webcast at www.InvestorCalendar.com.

The webcast will be available for replay through June 13th, 2009. A replay of the conference call will be accessible until May 13th, 2009 by dialing 877-660-6853 or (International) 201-612-7415 and entering the Account#: 286 and the Conference ID#: 316499.

About PURE Bioscience

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

    PURE Investor Contact:
    Paul G. Henning, Vice President
    Cameron Associates
    (212) 554-5462
    paul@cameronassoc.com


'/>"/>
SOURCE PURE Bioscience
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Greater Baltimore Committee to Announce Winners of 2009 Maryland Bioscience Awards at Ceremonies on March 12
2. Neurocrine Biosciences to Present at the Cowen and Company 29th Annual Health Care Conference
3. Seahorse Bioscience, Inc. Acquires BioProcessors Corp.
4. PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors
5. S*BIO Receives BioSpectrum Editors Choice, Emerging BioScience Company of Singapore Award
6. Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
7. Pressure BioSciences, Inc. to Present at the EdgeWater Research Partners Spring 2009 Micro/Small-Cap Investor Conference
8. EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone
9. INVO Bioscience Completes Reverse Merger
10. Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds
11. Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... ... solutions for clinical development reported today that it is launching two new additions ... company will be demonstrating new capabilities at the DIA 2017 Annual Meeting in ...
(Date:6/16/2017)... (PRWEB) , ... June 16, 2017 , ... ... device compliance and commercialization, has just announced two more sessions of its “From ... series will focus on the world of online templates for design control exercises. ...
(Date:6/15/2017)... ... June 15, 2017 , ... ... herbicides give farmers new options for managing Palmer amaranth and other broadleaf weeds ... say special precautions are necessary. Auxin herbicides are known to drift and to ...
(Date:6/15/2017)... TX (PRWEB) , ... June 15, 2017 , ... ... in Saranas, a promising new medical device startup. Dan Parsley, angelMD’s SVP of ... by angelMD members, and this angelMD syndicate is part of Saranas’ recently announced ...
Breaking Biology Technology:
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
(Date:3/22/2017)... March 21, 2017 Optimove , ... by retailers such as 1-800-Flowers and AdoreMe, today ... Recommendations and Replenishment. Using Optimove,s machine learning algorithms, ... product and replenishment recommendations to their customers based ... predictions of customer intent drawn from a complex ...
Breaking Biology News(10 mins):